US FDA clears Sarepta’s DMD treatment, but analysts caution doctors and patients may need time to regain trust after string of negative developments, including patient deaths.
Source: https://www.marketwatch.com/story/sarepta-finally-gets-some-good-news-a-patient-death-wasnt-its-dmd-drugs-fault-89880085